Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Visceral leishmaniasis or kala-azar is an endemic parasitic disease in some parts of the world which is characterized by fever, splenomegaly, and pancytopenia in most of the cases. Herein we report an 11 month-old male infant with diagnosis of kala-azar who presented with pallor, hepatosplenomegaly, failure to gain weight, and no history of fever. Surprisingly, fever started after beginning of meglumine antimoniate treatment in this patient. As far as we are aware of, this is a rare presentation of visceral leishmaniasis. Therefore, clinicians especially in endemic areas are highly recommended to include kala-azar among differential diagnosis of unexplained anemia without fever to prevent misdiagnosis of this potentially fatal, but treatable condition.
Abstract
Visceral leishmaniasis or kala-azar is an endemic parasitic disease in some parts of the world which is characterized by fever, splenomegaly, and pancytopenia in most of the cases. Herein we report an 11 month-old male infant with diagnosis of kala-azar who presented with pallor, hepatosplenomegaly, failure to gain weight, and no history of fever. Surprisingly, fever started after beginning of meglumine antimoniate treatment in this patient. As far as we are aware of, this is a rare presentation of visceral leishmaniasis. Therefore, clinicians especially in endemic areas are highly recommended to include kala-azar among differential diagnosis of unexplained anemia without fever to prevent misdiagnosis of this potentially fatal, but treatable condition.
참고문헌 (15)
- Mohebali M, "Visceral leishmaniasis in Iran : review of the epidemiological and clinical features", Iranian J Parasitol, 8, pp.348~358 (2013)
- Mohebali M, "Integrated visceral leishmaniasis surveillance system in primary care for children in Meshkin-Shahr district, north-western Islamic Republic of Iran", East Mediterr Health J, 16, pp.1050~1054 (2010)
- Alborzi A, "Visceral leishmaniasis;literature review and iranian experience", Iranian J Clin Infect Dis, 2, pp.99~108 (2007)
- Mohan A, "A rare presentation of visceral leishmaniasis without fever or splenomegaly in an elderly person", Eur J Intern Med, 18, pp.158~160 (2007)
- "Basic Laboratory Methods in Medical Parasitology" (1991)[URL]
- Hadighi R, "Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites", PLoS Medicine, 3, pp.0659~0667 (2006)
- Kazemi-Rad E, "Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach", Exp Parasitol, 135, pp.344~349 (2013)
- Mansour HEIDARI, "Overexpression of Ubiquitin and Amino Acid Permease Genes in Association with Antimony Resistance in Leishmania tropica Field Isolates", The Korean Journal of Parasitology, 51(4), pp.413~419 (2013), 대한기생충학ㆍ열대의학회
- Khadem-Erfan M B, "Down regulation of calcineurin gene is associated with Glucantime® resistance in Leishmania infantum", Iranian J Parasitol, 8, pp.359~366 (2013)
- McGwire BS, "Leishmaniasis: clinical syndromes and treatment", Q J Med, 107, pp.7~14 (2013)[DOI]
- Murray HW, "Treatment of visceral leishmaniasis(kala-azar) : a decade of progress and future approaches", Int J Infect Dis, 4, pp.158~177 (2000)
- Thakur CP, "A single high dose treatment of kala-azar with ambisome(amphotericin B lipid complex) : a pilot study", Int J Antimicrob Agents, 17, pp.67~70 (2001)
- Griensven JV, "Combination therapy for visceral leishmaniasis", Lancet Infect Dis, 10, pp.184~194 (2010)
- Ozlem Guzel Tunccan, "Visceral Leishmaniasis Mimicking Autoimmune Hepatitis, Primary Biliary Cirrhosis, and Systemic Lupus Erythematosus Overlap", The Korean Journal of Parasitology, 50(2), pp.133~136 (2012), 대한기생충학ㆍ열대의학회[DOI]
- Garcia LS, "Feigin and Cherry’s Textbook of Pediatric Infectious Diseases", pp.2920~2930 (2009), Saunders